Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 2.7B | 2.7B | 2.3B | 2.8B |
Cost of revenue | 1.2B | 1.1B | 981M | 1.1B |
Gross profit | 1.6B | 1.6B | 1.4B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 188M | 170M | 164M | 186M |
Other operating expenses | 9M | -25M | -27M | -17M |
Operating income | 793M | 838M | 696M | 1.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 338M | 338M | 339M | 349M |
Other income expense | 86M | 468M | 198M | 192M |
Pretax income | 608M | 968M | 555M | 855M |
Tax provision | 91M | 227M | 129M | 193M |
Net income | 517M | 741M | 426M | 662M |
Basic EPS | — | 0.6 | 0.3 | 0.5 |
Diluted EPS | — | 0.6 | 0.3 | 0.5 |
Basic average shares | — | 1.2B | 1.2B | 1.2B |
Diluted average shares | — | 1.2B | 1.2B | 1.2B |
EBITDA | 1.6B | 1.6B | 1.4B | 1.7B |
Net income from continuing op. | 517M | 741M | 426M | 662M |
Minority interests | -31M | -35M | -25M | -30M |
Preferred stock dividends | — | — | — | — |